Fibricheck Detection cApabilities for Atrial Fibrillation
NCT ID: NCT06282380
Last Updated: 2024-06-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
330 participants
INTERVENTIONAL
2024-02-26
2024-06-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Detection of Atrial Fibrillation in Different Patient Target Groups Using the FibriCheck Smartphone Application
NCT03509493
The Validation of the FibriCheck Application for the Detection of Atrial Fibrillation
NCT03620656
REal-worLd vAlidaTION of PhotoPlehtysmoGraphy (for Atrial Fibrillation Detection)
NCT06028893
The Effect of a Case-finding App on the Detection Rate of Atrial Fibrillation in Primary Care Patients
NCT04545723
Atrial Fibrillation Screening in Nursing Homes
NCT03860246
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
FibriCheck Mobile Application measurements
Participants will perform one measurement using the FibriCheck Mobile Application and the result will be compared with the ground truth.
FibriCheck Mobile Application
PPG measurement with reference diagnosis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FibriCheck Mobile Application
PPG measurement with reference diagnosis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Capable of independently performing FibriCheck recordings (researcher-observed);
* Cardiology patients, hospitalized/in-clinic or consulting the cardiac outpatient clinic, with or without a diagnosis of atrial fibrillation.
Exclusion Criteria
* Individuals enrolled in another clinical trial;
* Individuals with physical or medical characteristics that prevent them from successfully taking a measurement e.g. extreme callus (i.e., rough or thickened area of skin fingertip), tremor, cognitive impairment, Parkinson's disease;
* Pregnant and/or nursing women.
22 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Qompium NV
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Northwestern Medicin
Chicago, Illinois, United States
New York Presebyterian Queens
New York, New York, United States
OU Medicine College
Oklahoma City, Oklahoma, United States
University Hospital Antwerp
Antwerp, , Belgium
Ziekenhuis Oost-Limburg
Genk, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FDA-AF study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.